maximising business analytics to drive evidence based
play

Maximising Business Analytics to drive evidence based decisions in - PowerPoint PPT Presentation

Maximising Business Analytics to drive evidence based decisions in Cancer Care HISA Health Data Analytics Conference 2017 Gary Lakin| CEO |Charm Health Cassandra Schultz | Manager | Aginic AGENDA Current State About CHARM


  1. Maximising Business Analytics to drive evidence based decisions in Cancer Care HISA Health Data Analytics Conference 2017 Gary Lakin| CEO |Charm Health Cassandra Schultz | Manager | Aginic

  2. AGENDA  Current State  About CHARM™  Understanding the Market  Clinical Data Streams  Engaging with Industry thought leaders  CHARM Business Analytics Solution  Scenario driven demonstration  Business Analytics Delivers

  3. Current State  Rapid change, emerging technologies, increasing demand on workforce & cost pressures  Digital transformation  Advanced reporting requirements to support clinical governance  Increasing demand for health data analytics to deliver insights into patient care and service delivery

  4. About CHARM™  Australia’s leading best of breed oncology information system supporting therapeutic management of cancer  Charm Health now part of The Citadel Group  Over 75,000 patients have had their treatment managed using CHARM in the past decade  Over 3,500 users at over 100 facilities around Australia & NZ use Charm solutions  Extensive untapped, unrealised data captured in CHARM through routine use

  5. Understanding the market  Translating CHARM data to: – Illuminate health care trends, track diseases, cycle progression and survivorship to support future benchmarking – Monitor protocol variance, provider prescribing patterns and treatment efficacy – Evaluate service delivery and resource utilisation to improve operational efficiencies – Strengthen stakeholder engagement to promote quality and clinical improvement

  6. Clinical Data Streams 4 critical streams of clinical data to deliver insights: • Treatment Pathways - disease groups, disease systems, cycle progression and completion, death, survivorship • Doses of medicines - prescribed vs administered, dose intensity & frequency, protocol dose variation, Provider prescribing patterns • Patient Appointments/Scheduling - service delivery, resource optimisation • Safety and Quality - dosing parameters to minimise adverse events, optimise patient treatment & outcomes

  7. Engaging Industry Thought Leaders Why Aginic?  Innovative analytics and digital business consultancy  Using cutting edge technology including cloud platforms, in- memory data analytics, web tech & machine learning  Match the right tech with the right user requirements  Deliver advanced, intuitive analytics ready to be actioned  Apply an Agile delivery model  Outcomes focused  Demonstrate rapid results

  8. CHARM™ Business Analytics Solution  Data services provided within a database  Dashboard Solution using Qlik  Focuses on Key data streams  De-identified, amalgamated data flows into Data Lake  Interpreted and presented through interactive visualisations  Supports user-driven interrogation and mashups

  9. Scenario Demonstration  How many Breast patients have been treated in the past 3 years?  Who are the top 5 treating providers?  What are the 5 most commonly used protocols?  How many of these patients aged between 45- 65 years are still alive  Which drugs are getting dose overrides and by whom?  Which type of appointments have the longest waiting time?

  10. CHARM Business Analytics Delivers  Real time comprehensive data surveillance  Insights into patient care and service delivery  Monitor trends in cancer patient populations  Identify business improvement opportunities  Support improved clinical decision making  Drive quality and safety  Support future benchmarking and predictive analytics

  11. Questions?

Recommend


More recommend